{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:28:27Z","timestamp":1794533307326,"version":"4.9.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":284,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101484","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:50:55Z","timestamp":1792054255000},"page":"101484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Solasodine-derived steroidal alkaloids as dual modulators of PI3K\/Akt signaling and metabolic reprogramming in breast cancer"],"prefix":"10.1016","volume":"49","author":[{"given":"Precious","family":"Idakwoji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma","family":"Nwafor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claribel","family":"Okorie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Favor","family":"Udoeyop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mannir","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzuazokaro","family":"Agatemor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehu Ali","family":"Auwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitalis","family":"Ezeizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulahi Momoh","family":"Jimoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10299","key":"10.1016\/j.ctarc.2026.101484_bib0002","first-page":"132","article-title":"Molecular alterations in triple-negative breast cancer","volume":"398","author":"Denkert","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/biom13010093","article-title":"PI3K-AKT-targeting breast cancer treatments: natural products and synthetic compounds","volume":"13","author":"Yuan","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101484_bib0004","first-page":"88","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"21","author":"Thorpe","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101484_bib0005","first-page":"406","article-title":"PI3K inhibition in breast cancer: mechanisms of resistance","volume":"18","author":"Bosch","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101484_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104404","article-title":"Navigating the complexity of PI3K\/AKT pathway in HER2-negative breast cancer","volume":"200","author":"Sirico","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ctarc.2026.101484_bib0007","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-mutated breast cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101484_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41523-024-00648-0","article-title":"Gedatolisib efficacy in breast cancer models","volume":"10","author":"Rossetti","year":"2024","journal-title":"NPJ. Breast. Cancer"},{"issue":"6551","key":"10.1016\/j.ctarc.2026.101484_bib0009","article-title":"Metabolic reprogramming and cancer progression","volume":"373","author":"Faubert","year":"2021","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101484_bib0010","first-page":"593","article-title":"Tumour fatty acid metabolism","volume":"21","author":"Hoy","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0011","first-page":"283","article-title":"The emerging hallmarks of cancer metabolism","volume":"33","author":"Pavlova","year":"2021","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101484_bib0012","first-page":"74","article-title":"The PI3K\u2013AKT network at the interface of metabolism","volume":"21","author":"Hoxhaj","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ctarc.2026.101484_bib0013","first-page":"563","article-title":"Carbon metabolism supports tumor growth","volume":"3","author":"Li","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ctarc.2026.101484_bib0014","first-page":"87","article-title":"Solasodine glycosides: anticancer properties","volume":"505","author":"Cham","year":"2021","journal-title":"Cancer Lett."},{"issue":"15","key":"10.1016\/j.ctarc.2026.101484_bib0015","first-page":"4561","article-title":"Bioactivities of glycoalkaloids and their aglycones from Solanum species","volume":"69","author":"Milner","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"7629","key":"10.1016\/j.ctarc.2026.101484_bib0016","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20554","article-title":"Overcoming resistance by targeting PI3K\u03b3","volume":"539","author":"De Henau","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0017","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends. Biochem. Sci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101484_bib0018","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101484_bib0019","first-page":"61","article-title":"Glycolysis, tumor metabolism, and therapy","volume":"4","author":"Alfarouk","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","article-title":"Emerging roles of lipid metabolism in cancer metastasis","volume":"16","author":"Luo","year":"2017","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101484_bib0021","first-page":"681","article-title":"Lipid metabolism in cancer: new perspectives","volume":"21","author":"Broadfield","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101484_bib0022","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41419-020-2297-3","article-title":"Lipid droplets in cancer","volume":"11","author":"Cruz","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0023","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","article-title":"Mitochondria and cancer","volume":"166","author":"Vyas","year":"2016","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101484_bib0025","first-page":"483","article-title":"Is Akt the \u201cWarburg kinase\u201d?","volume":"356","author":"Robey","year":"2015","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101484_bib0026","first-page":"130","article-title":"The multifaceted role of mTORC1 in the control of lipid metabolism","volume":"14","author":"Ricoult","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101484_bib0027","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMP-activated protein kinase: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0028","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0029","first-page":"283","article-title":"The emerging hallmarks of cancer metabolism","volume":"33","author":"Pavlova","year":"2021","journal-title":"Cell Metab."},{"issue":"6551","key":"10.1016\/j.ctarc.2026.101484_bib0030","article-title":"Metabolic reprogramming and cancer progression","volume":"373","author":"Faubert","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ctarc.2026.101484_bib0031","article-title":"Anticancer mechanisms of steroidal alkaloids","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101484_bib0032","article-title":"Antitumor effects of solasodine in cancer cells","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"14","key":"10.1016\/j.ctarc.2026.101484_bib0033","first-page":"1459","article-title":"Steroidal glycoalkaloids: structure and biological activity","volume":"68","author":"Roddick","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ctarc.2026.101484_bib0034","article-title":"Solamargine induces apoptosis via multiple signaling pathways","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed. PharmacOther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0035","first-page":"123","article-title":"Mechanisms of apoptosis induced by steroidal alkaloids in cancer cells","volume":"21","author":"Ding","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ctarc.2026.101484_bib0036","article-title":"Solasodine regulates AMPK signaling and metabolic pathways","volume":"379","author":"Su","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ctarc.2026.101484_bib0037","article-title":"Nanoparticle delivery of natural alkaloids in cancer therapy","volume":"612","author":"Zhang","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101484_bib0038","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","article-title":"Targeting the PI3K pathway in cancer","volume":"15","author":"Janku","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101484_bib0039","first-page":"168","article-title":"mTOR signaling in breast cancer progression","volume":"526","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101484_bib0040","article-title":"Natural compounds targeting receptor tyrosine kinases in cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0041","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","article-title":"Oxidative stress and cancer","volume":"12","author":"Sosa","year":"2013","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101484_bib0042","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"issue":"W1","key":"10.1016\/j.ctarc.2026.101484_bib0043","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and tools for target prediction","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic. Acids. Res."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101484_bib0044","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0045","first-page":"375","article-title":"PI3K pathway alterations in cancer: mechanisms and clinical implications","volume":"169","author":"Yuan","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101484_bib0046","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101484_bib0047","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0048","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect and cancer metabolism","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends. Biochem. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0049","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondrial metabolism in cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101484_bib0050","first-page":"681","article-title":"Lipid metabolism and cancer progression","volume":"21","author":"Broadfield","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101484_bib0051","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-nutr-071812-161148","article-title":"AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels","volume":"34","author":"Hardie","year":"2021","journal-title":"Annu. Rev. Nutr."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101484_bib0052","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0053","first-page":"283","article-title":"Cancer cell metabolism: new hallmarks of cancer","volume":"33","author":"Pavlova","year":"2021","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0056","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"5930","key":"10.1016\/j.ctarc.2026.101484_bib0054","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101484_bib0057","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2021","journal-title":"Oncogenesis."},{"key":"10.1016\/j.ctarc.2026.101484_bib0058","article-title":"Steroidal alkaloids inhibit PI3K\/akt signaling in cancer cells","volume":"150","author":"Zhang","year":"2022","journal-title":"Biomed. PharmacOther"},{"issue":"18","key":"10.1016\/j.ctarc.2026.101484_bib0059","first-page":"9876","article-title":"Solasodine suppresses Akt phosphorylation in tumor models","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101484_bib0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","article-title":"Targeting the PI3K pathway in cancer: are we making headway?","volume":"15","author":"Janku","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101484_bib0061","first-page":"168","article-title":"mTOR signaling and its role in breast cancer progression","volume":"526","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101484_bib0062","article-title":"Natural compounds targeting receptor tyrosine kinases in cancer therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0063","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.arr.2012.10.004","article-title":"Oxidative stress and cancer: an overview","volume":"12","author":"Sosa","year":"2013","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101484_bib0064","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ctarc.2026.101484_bib0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s44371-025-00170-7","article-title":"Exploring QSAR, molecular docking, molecular dynamics and pharmacokinetics for 3,4-dihydro-2H,6H-pyrimido[1,2-c][1,3]benzothiazin-6-iminederivatives targetting plasmodium falciparum dihydroorotate dehydrogenase","volume":"2","author":"Dhingra","year":"2025","journal-title":"Discov. Chem."},{"key":"10.1016\/j.ctarc.2026.101484_bib0066","article-title":"Targeting cellular metabolism in cancer therapy","volume":"4","author":"Zhao","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101484_bib0067","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria in cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101484_bib0068","article-title":"Lipid metabolism reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2021","journal-title":"Oncogenesis."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101484_bib0069","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK and cancer metabolism regulation","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101484_bib0070","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5930","key":"10.1016\/j.ctarc.2026.101484_bib0071","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Metabolic requirements of proliferating cells","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101484_bib0072","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT signaling in cancer biology","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0073","first-page":"375","article-title":"PI3K pathway mechanisms in cancer","volume":"169","author":"Yuan","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101484_bib0074","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in metabolism and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101484_bib0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK signaling and cellular energy regulation","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101484_bib0076","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect in cancer metabolism","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends. Biochem. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0077","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Mitochondrial metabolism in cancer","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101484_bib0078","first-page":"681","article-title":"Lipid metabolism in cancer progression","volume":"21","author":"Broadfield","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00037.2024","article-title":"Metabolic adaptations in cancer progression","volume":"106","author":"Peng-Winkler","year":"2026","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101484_bib0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","article-title":"Targeting PI3K pathway in cancer therapy","volume":"15","author":"Janku","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101484_bib0081","first-page":"20","article-title":"Combined targeting of PI3K and metabolism in cancer","volume":"12","author":"Castel","year":"2022","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101484_bib0082","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101484_bib0083","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.ctarc.2026.101484_bib0084","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment in breast cancer progression","volume":"79","author":"Hinshaw","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101484_bib0085","article-title":"Nanoparticle delivery systems for natural compounds in cancer therapy","volume":"612","author":"Zhang","year":"2022","journal-title":"Int. J. Pharm."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600393X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600393X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:18:37Z","timestamp":1794532717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422600393X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":85,"alternative-id":["S246829422600393X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101484","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solasodine-derived steroidal alkaloids as dual modulators of PI3K\/Akt signaling and metabolic reprogramming in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101484"}}